Dr. Victor Ling is the founding President and Scientific Director of TFRI. He is an authority on multi-drug resistance in cancer, and is well-known for his discovery of P-glycoprotein, the first molecule identified to be responsible for drug resistance. Most recently, Dr. Ling was the Vice President of Discovery Research at the BC Cancer Agency. Dr. Ling provides overall leadership to TFRI, the development of translational research projects, relationships with stakeholders, and TFRI communications. See more biographical information on Dr. Ling's President and Scientific Director page.
Darrell Fox is the younger brother of Terry Fox, for whom the Terry Fox Foundation and the Terry Fox Research Institute (TFRI) are named. In 1980, at the age of 17, Darrell joined Terry (and Terry’s best friend Doug Alward) on his Marathon of Hope in Saint John, New Brunswick. Darrell has had a long history of involvement with his brother's legacy. In 1990, Darrell became the Provincial Director for The Terry Fox Foundation in British Columbia. In 1994, he moved to the National Office in Toronto, Ontario where he served for two years as the Assistant National Director and then National Director of the Terry Fox Foundation from 1996 to 2009. Today Darrell serves on TFRI’s Board of Directors and is a Senior Advisor to the Institute. A holder of the Queen’s Diamond Jubilee Medal, Darrell continues to be involved in projects and activities related to Terry Fox and his 35-year legacy.
Stephen Herst is Chief Operating Officer. Stephen was previously Director of Research Development at the BC Cancer Research Centre, and held executive positions at two successful Networks of Centres of Excellence - the Canadian Genetic Diseases Network and the Protein Engineering Network of Centres of Excellence. He was part of the team that launched the Canadian Bioinformatics Workshops, and was involved in the early development of the Human Genome Organization in Europe. More recently, Stephen has been a project manager for a number of large-scale genomics research programs at the BC Cancer Agency.
Kelly Curwin is Chief Communications Officer. She holds an MBA in Communications Management and Public Relations from Royal Roads University (Victoria) and an Honours Bachelor of Journalism degree from Carleton University (Ottawa). As a communications consultant, Kelly conducted work for the Fraser Health Authority, Trillium Health Centre in Mississauga, the University of Waterloo and KCI (formerly Ketchum Canada Inc.) in Toronto. She served in public relations at McMaster University for more than a decade and is a former editor of Nunavut's Nunatsiaq News, based in Iqaluit. An award-winning writer and editor, she is a former volunteer for the Wellwood Resource Centre in Hamilton.
Susan is TFRI’s Finance Administrator. She brings experience from the utilities and engineering industries and previously worked at the BC Cancer Agency where she managed research funds. Susan handles all financial matters concerning TFRI research programs.
Marlene is TFRI’s Executive and Events Assistant. She has worked in medical and research offices, including the Cumming School of Medicine at the University of Calgary, as well as industry. Marlene was most recently with Ernst and Young and brings extensive office administration experience to her role.
Catherine is TFRI’s Research Communications Specialist. She holds masters degrees in Physics and in Science Communication. Catherine has previously worked within the press office of the European Southern Observatory in Munich, Germany and most recently was part of the communications team for the Royal Bournemouth and Christchurch hospitals in England.
Russell is TFRI’s Senior Research Programs Manager. He holds a doctorate in Molecular Evolution from Simon Fraser University and has an extensive background in the management of large-scale research projects. Russell has worked for Dalhousie University, the Centre for Molecular Medicine and Therapeutics at the University of British Columbia and most recently at the BC Cancer Agency Genome Sciences Centre.